LinkedIn YouTube Bluesky
Search
English / Français
Ethics Portal
  • Who We Are
      • Who We Are
      • About Us
      • Business Model
      • Our Strategy 2023-2025
      • Statutes, By-Laws & Policies
      • Governance & Team
      • Annual Reports
      • Careers & RFPs
  • What We Do
      • What We Do
      • Licensing for Public Health
      • mRNA Technology Transfer Hub Programme
      • Disease Areas
      • Addressing Children’s Needs
      • Prioritising Medicines for Licensing
      • Long-Acting Therapeutics
      • Focus areas
      • Biotherapeutics
      • Local and Regional Manufacturing
      • Pandemic Preparedness and Response
      • Upstream Access
      • Technology Transfer
      • Patent Information Tools
      • MedsPaL
      • LAPaL
  • Progress
      • Progress
      • Licences
      • Prioritisation
      • Agreements with Innovators
      • Access to Medicines Tracker
      • Contribution to Universal Health Coverage
      • Endorsements
      • Impact
  • News & Publications
      • News
        & Publications
      • News, Events & Press Releases
      • Messages from the Executive Director
      • MPP in the Media
      • MPP Publications
      • Related Publications
      • Newsletters & Updates
  • Partners
      • Partners
      • Partnering with MPP
      • Funders
      • Our Stories
      • Voices from Friends of MPP
      • Voices from the Frontline
      • I am part of the DTG story
      • How to Give or Get a Licence
  • Contact Us
English / Français
Ethics Portal
Search

Related Publications

Trilateral study by the World Health Organization (WHO), World Intellectual Property Organization (WIPO) and World Trade Organization (WTO) Public health is inherently a global challenge and thus assumes high priority for international cooperation. The World Health Organization (WHO) is the directing and coordinating authority for health, but the interaction between health issues and other policy domains – human rights, development policy, intellectual property (IP) and international trade – creates a strong rationale for cooperation and coordination between the WHO and other international organizations such as the World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO).

news & publications » Related Publications

WHO, WIPO, WTO: Promoting access to medical technologies and innovation – Intersections between public health, intellectual property and trade

5 February 2013

Share page:
Facebook
Linkedin
Bluesky

Contact Us

Press and Media

About Us

The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.

To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.

MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.

MPP Logo
  • About Us
  • MedsPaL
  • licences
  • Careers & RFPs
  • Privacy Policy
Follow us
LinkedIn YouTube Bluesky

Founded & funded by

Unitaid Logo

Other funders

Designed and built by ACW